These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4150719)

  • 41. [Depot-neuroleptics in the treatment of schizophrenia].
    Schipper JA
    Ned Tijdschr Geneeskd; 1971 Apr; 115(16):707-9. PubMed ID: 5551427
    [No Abstract]   [Full Text] [Related]  

  • 42. [Antipsychotic medication in psychosocial rehabilitation].
    Zoltán D
    Neuropsychopharmacol Hung; 2005 Jun; 7(2):83-7. PubMed ID: 16167460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early hospital experience with fluphenazine decanoate.
    Small JG; Kellams J
    Dis Nerv Syst; 1974 Oct; 35(10):453-6. PubMed ID: 17894058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [30 years of neuroleptic chemotherapy in psychiatry (evolution of the concept and practice)].
    Deniker P
    Bull Acad Natl Med; 1982 Jan; 166(1):113-21. PubMed ID: 6129053
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric outpatients].
    Kurz A; Delius-Stute H; Rettig K; Schwalen S
    MMW Fortschr Med; 2003 Oct; 145(42):55. PubMed ID: 14655446
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical experience with depot neuroleptics.
    Bakke O
    Acta Psychiatr Scand Suppl; 1973; 246():32-4. PubMed ID: 4588180
    [No Abstract]   [Full Text] [Related]  

  • 47. [Trial at the guidance center of ixelles of a major neuroleptic drug: anatensol decanoate].
    Berliner J
    Acta Psychiatr Belg; 1974 May; 74(3):305-16. PubMed ID: 4455024
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia.
    Dursun S
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780
    [No Abstract]   [Full Text] [Related]  

  • 50. [New perspectives offered by an injectable delayed-action neuroleptic: fluphenazine enanthate].
    Lambert PA; Midenet M; Midenet J; Marcou G; Bouchardy M
    Ann Med Psychol (Paris); 1966 May; 124(5):702-7. PubMed ID: 5941462
    [No Abstract]   [Full Text] [Related]  

  • 51. [Increase of sulfobromophthalein clearance by phenothiazines].
    Denis P; Le Leannec AM; Benhamou JP
    Nouv Presse Med; 1973 Dec; 2(43):2881-3. PubMed ID: 4149342
    [No Abstract]   [Full Text] [Related]  

  • 52. [Implications of delayed-action drugs].
    Biéder J
    Ann Med Psychol (Paris); 1970 Oct; 2(3):424-7. PubMed ID: 5481457
    [No Abstract]   [Full Text] [Related]  

  • 53. Ethical use of long-acting medications in the treatment of severe and persistent mental illnesses.
    Roberts LW; Geppert CM
    Compr Psychiatry; 2004; 45(3):161-7. PubMed ID: 15124145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Indications for, limitations, and hazards of neuroleptic agents].
    Hoes MJ
    Ned Tijdschr Geneeskd; 1980 Apr; 124(17):647-53. PubMed ID: 6104304
    [No Abstract]   [Full Text] [Related]  

  • 55. [Depot Neuroleptic preparations in psychiatric practice (author's transl)].
    Svestka J; Bártová D; Cesková E; Rysánek R
    Cesk Psychiatr; 1981 Jun; 77(3):187-97. PubMed ID: 6119161
    [No Abstract]   [Full Text] [Related]  

  • 56. Depot neuroleptic usage in adults with learning disabilities.
    Gravestock S
    J Intellect Disabil Res; 1996 Feb; 40 ( Pt 1)():17-23. PubMed ID: 8930053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Social aspects of therapy with depot neuroleptics in the Federal Republic of Germany.
    Haring C; Tegeler J; Lehmann E; Ptock WD
    Acta Psychiatr Belg; 1981; 81(2):189-202. PubMed ID: 6117189
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Serum creatine kinase in patients treated with depot neuroleptics. A pilot study].
    Bjørndal F; Lauritsen B; Lyngbye J; Waarst S
    Ugeskr Laeger; 1979 Dec; 141(51):3514-6. PubMed ID: 44041
    [No Abstract]   [Full Text] [Related]  

  • 59. Experience with depot neuroleptics in ambulatory practice.
    Fiolet J
    Acta Psychiatr Belg; 1981; 81(2):182-8. PubMed ID: 6117188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review.
    Otręba M; Kośmider L
    J Appl Toxicol; 2021 Jan; 41(1):82-94. PubMed ID: 32852120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.